• 1
    Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer. 1990; 4: 464469.
  • 2
    Evans AE, Jenkin RD, Sposto R, et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg. 1990; 72: 572582.
  • 3
    Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol. 1995; 3: 166178.
  • 4
    Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized Phase III study. J Clin Oncol. 1999; 3: 832845.
  • 5
    Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol. 1999; 7: 21272136.
  • 6
    Bouffet E. Embryonal tumours of the central nervous system. Eur J Cancer. 2002; 8: 11121120.
  • 7
    Strother D, Ashley D, Kellie SJ, et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol. 2001; 10: 26962704.
  • 8
    Osoba D, Murray N, Gelmon K, et al. Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy. Oncology (Huntingt). 1994; 4: 6165; discussion, 65–66, 69.
  • 9
    Tanner JM, Whitehouse RH. Growth and development record, Tanner–Whitehouse (1970). Ware, UK: Castlemead Publications, 1984.
  • 10
    Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993; 328: 17251731.
  • 11
    Reilly JJ, Odame I, McColl JH, McAllister PJ, Gibson BE, Wharton BA. Does weight for height have prognostic significance in children with acute lymphoblastic leukemia? Am J Pediatr Hematol Oncol. 1994; 3: 225230.
  • 12
    Tyc VL, Vallelunga L, Mahoney S, Smith BF, Mulhern RK. Nutritional and treatment-related characteristics of pediatric oncology patients referred or not referred for nutritional support. Med Pediatr Oncol. 1995; 5: 379388.
  • 13
    Baron MA, Duncan DS, Green GJ, et al. Efficacy and safety of radiologically placed gastrostomy tubes in paediatric haematology/oncology patients. Med Pediatr Oncol. 2000; 3: 177182.
  • 14
    Mauer AM, Burgess JB, Donaldson SS, et al. Special nutritional needs of children with malignancies: a review. JPEN J Parenter Enteral Nutr. 1990; 3: 315324.
  • 15
    Capra S, Ferguson M, Ried K. Cancer: impact of nutrition intervention outcome—nutrition issues for patients. Nutrition. 2001; 9: 769772.
  • 16
    Elhasid R, Laor A, Lischinsky S, Postovsky S, Weyl Ben Arush M. Nutritional status of children with solid tumors. Cancer. 1999; 1: 119125.
  • 17
    Faithfull S. Patients' experiences following cranial radiotherapy: a study of the somnolence syndrome. J Adv Nurs. 1991; 8: 939946.
  • 18
    Charuhas PM. Nutrition management of cancer. In: WilliamsCP, editor. Pediatric manual of clinical dietetics. Chicago: American Dietetic Association, 1998: 151160.
  • 19
    Andrassy RJ, Chwals WJ. Nutritional support of the pediatric oncology patient. Nutrition. 1998; 1: 124129.
  • 20
    Klawitter BM. Pediatric enteral nutrition support. In: WilliamsCP, editor. Pediatric manual of clinical dietetics. Chicago: American Dietetic Association, 1998: 479502.
  • 21
    Mathew P, Bowman L, Williams R, et al. Complications and effectiveness of gastrostomy feedings in pediatric cancer patients. J Pediatr Hematol Oncol. 1996; 1: 8185.
  • 22
    den Broeder E, Lippens RJ, van't Hof MA, et al. Effects of naso-gastric tube feeding on the nutritional status of children with cancer. Eur J Clin Nutr. 1998; 52: 494500.
  • 23
    Pietsch JB, Ford C, Whitlock JA. Nasogastric tube feedings in children with high-risk cancer: a pilot study. J Pediatr Hematol Oncol. 1999; 2: 111114.
  • 24
    Deswarte-Wallace J, Firouzbakhsh S, Finklestein JZ. Using research to change practice: enteral feedings for pediatric oncology patients. J Pediatr Oncol Nurs. 2001; 5: 217223.
  • 25
    Aquino VM, Smyrl CB, Hagg R, McHard KM, Prestridge L, Sandler ES. Enteral nutritional support by gastrostomy tube in children with cancer. J Pediatr. 1995; 1: 5862.
  • 26
    Skolin I, Hernell O, Larsson MV, Wahlgren C, Wahlin YB. Percutaneous endoscopic gastrostomy in children with malignant disease. J Pediatr Oncol Nurs. 2002; 19: 154163.
  • 27
    Erkurt E, Erkisi M, Tunali C. Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy. J Exp Clin Cancer Res. 2000; 19: 431439.
  • 28
    Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R. Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy. Eur J Cancer. 1997; 33: 7579.
  • 29
    Schmid I, Stachel DK, Freudenberg S, Schmitt M, Schuster F, Haas RJ. Megestrol acetate to correct the nutritional status in an adolescent with growth hormone deficiency. Increase of appetite and body weight but only by increase of body water and fat mass followed by profound cortisol and testosterone depletion. Klin Padiatr. 2002; 2: 5457.